Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $586.90 million. The enterprise value is $1.41 billion.
| Market Cap | 586.90M |
| Enterprise Value | 1.41B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 52.40 million shares outstanding. The number of shares has increased by 3.98% in one year.
| Shares Outstanding | 52.40M |
| Shares Change (YoY) | +3.98% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 2.22% |
| Owned by Institutions (%) | 68.95% |
| Float | 51.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.94 |
| PS Ratio | 0.50 |
| Forward PS | 0.75 |
| PB Ratio | 0.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.55 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.36.
| Current Ratio | 1.08 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.92 |
Financial Efficiency
Return on equity (ROE) is -76.20% and return on invested capital (ROIC) is -34.34%.
| Return on Equity (ROE) | -76.20% |
| Return on Assets (ROA) | -29.40% |
| Return on Capital (ROIC) | -34.34% |
| Revenue Per Employee | $740,875 |
| Profits Per Employee | -$353,250 |
| Employee Count | 1,600 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, EBS has paid $6.70 million in taxes.
| Income Tax | 6.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.21% in the last 52 weeks. The beta is 1.62, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +56.21% |
| 50-Day Moving Average | 6.84 |
| 200-Day Moving Average | 3.44 |
| Relative Strength Index (RSI) | 75.37 |
| Average Volume (20 Days) | 3,075,897 |
Short Selling Information
The latest short interest is 5.19 million, so 9.91% of the outstanding shares have been sold short.
| Short Interest | 5.19M |
| Short Previous Month | 5.94M |
| Short % of Shares Out | 9.91% |
| Short % of Float | 10.12% |
| Short Ratio (days to cover) | 2.15 |
Income Statement
In the last 12 months, EBS had revenue of $1.19 billion and -$565.20 million in losses. Loss per share was -$10.94.
| Revenue | 1.19B |
| Gross Profit | 488.30M |
| Operating Income | -539.00M |
| Pretax Income | -558.50M |
| Net Income | -565.20M |
| EBITDA | -345.80M |
| EBIT | -464.20M |
| Loss Per Share | -$10.94 |
Balance Sheet
The company has $79.00 million in cash and $905.90 million in debt, giving a net cash position of -$826.90 million or -$15.78 per share.
| Cash & Cash Equivalents | 79.00M |
| Total Debt | 905.90M |
| Net Cash | -826.90M |
| Net Cash Per Share | -$15.78 |
| Equity (Book Value) | 663.90M |
| Book Value Per Share | 12.67 |
| Working Capital | 52.20M |
Cash Flow
In the last 12 months, operating cash flow was -$84.90 million and capital expenditures -$47.30 million, giving a free cash flow of -$132.20 million.
| Operating Cash Flow | -84.90M |
| Capital Expenditures | -47.30M |
| Free Cash Flow | -132.20M |
| FCF Per Share | -$2.53 |
Margins
Gross margin is 41.19%, with operating and profit margins of -45.47% and -47.68%.
| Gross Margin | 41.19% |
| Operating Margin | -45.47% |
| Pretax Margin | -47.11% |
| Profit Margin | -47.68% |
| EBITDA Margin | -29.17% |
| EBIT Margin | -39.16% |
| FCF Margin | -11.15% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.98% |
| Shareholder Yield | -3.98% |
| Earnings Yield | -96.30% |
| FCF Yield | -22.53% |
Analyst Forecast
The average price target for EBS is $8.00, which is -28.57% lower than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | -28.57% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 0.14 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.14 |
| Piotroski F-Score | 5 |